Tumorigenesis and Neoplastic Progression Cystic Duct Dilatations and Proliferative Epithelial Lesions in Mouse Mammary Glands upon Keratin 5 Promoter-Driven Overexpression of Cyclooxygenase-2

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• STEROIDRECEPTORSANDPROLIFERATIONIN THE HUMANBREAST Results and Discussion Distribution of ER in Normal Human Breast Lobules

  2006cited by this paper
• Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

  2004cited by this paper
• Aromatase inhibitors in breast cancer.

  2003cited by this paper
• Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.

  2003cited by this paper
• Gene expression profiles of human breast cancer progression

  2003cited by this paper
• Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes.

  2003cited by this paper
• Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.

  2003cited by this paper
• Flow cytometric detection of spontaneous apoptosis in human breast cancer using the TUNEL-technique.

  2003cited by this paper
• Aromatase inhibitors for breast cancer: lessons from the laboratory

  2003cited by this paper
• Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.

  2002cited by this paper
• The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition.

  2002cited by this paper
• Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis

  2002influential reference
• Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.

  2002cited by this paper
• Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer

  2002cited by this paper
• Regulation of estrogen synthesis in postmenopausal women.

  2002cited by this paper
• Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

  2002cited by this paper
• Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice*

  2001influential reference
• Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin

  2001influential reference
• Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.

  2001cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Cyclooxygenases: structural, cellular, and molecular biology.

  2000cited by this paper
• 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2.

  2000cited by this paper
• The mammary myoepithelial cell - Cinderella or ugly sister?

  2000cited by this paper
• Is Estradiol a Genotoxic Mutagenic Carcinogen ? *

  2000cited by this paper
• Role of DNA adducts in hormonal carcinogenesis.

  2000cited by this paper
• Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.

  2000cited by this paper
• Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells.

  1999cited by this paper
• Prostaglandin‐H‐synthase isozyme expression in normal and neoplastic human skin

  1999cited by this paper
• The transition from hyperplasia to invasive carcinoma of the breast

  1999cited by this paper
• Prostanoid receptors: structures, properties, and functions.

  1999cited by this paper
• Risk of Breast Cancer in Japanese Women with Benign Breast Disease

  1999cited by this paper
• Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.

  1999cited by this paper
• Cytogenetics of benign breast lesions

  1998cited by this paper
• Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: Suppression of skin tumor promotion by inhibition of prostaglandin H synthase‐2

  1998cited by this paper
• Cyclooxygenase-2 as a therapeutic target

  1998cited by this paper
• Carcinomas of the breast showing myoepithelial cell differentiation

  1998cited by this paper
• Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.

  1996cited by this paper
• Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis.

  1994cited by this paper
• Risk factors for breast cancer in women with proliferative breast disease.

  1985cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper

• Chemoprophylactic activity of nitazoxanide in experimental model of mammary gland carcinoma in rats

  2020cites this paper
• Expression of COX-2, p16, and Ki67 in the range from normal breast tissue to breast cancer.

  2020cites this paper
• Comparative pharmacokinetics study of anastrozole after single administration and combination with celecoxib

  2018cites this paper
• Angelica sinensis Supercritical Fluid CO2 Extract Attenuates D-Galactose-Induced Liver and Kidney Impairment in Mice by Suppressing Oxidative Stress and Inflammation

  2018cites this paper
• Cellular and Molecular Mechanisms of Tumor Promotion

  2018cites this paper
• Protective Effect of SFE-CO2 of Ligusticum chuanxiong Hort Against d-Galactose-Induced Injury in the Mouse Liver and Kidney

  2017cites this paper
• Effect of β-sitosterol against methyl nitrosourea-induced mammary gland carcinoma in albino rats

  2016cites this paper
• Influencia del consumo de antiinflamatorios no esteroideos en la incidencia de cáncer de mama: = Influence of non-streroidal antiinflammatory drugs use on breast cancer incidence

  2015cites this paper
• Hepatoprotective effect of the flavonoid fraction isolated from the flower of Inula britannica against D-Galactosamine-induced hepatic injury.

  2013cites this paper
• Transgenic insulin‐like growth factor‐1 stimulates activation of COX‐2 signaling in mammary glands

  2012cites this paper
• Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF-κB pathway.

  2012cites this paper
• La 7β-hydroxy-épiandrostérone dans des modèles in vitro de cancer du sein : effets anti-estrogéniques et rôle des récepteurs des estrogènes

  2012cites this paper
• Ganoderma applanatum terpenes protect mouse liver against benzo(α)pyren-induced oxidative stress and inflammation.

  2011cites this paper
• Cellular and Molecular Mechanisms of Tumor Promotion

  2010cites this paper
• Mammary Epithelial Cell Subtype-Specific Analysis of Ras Pathway Activation

  2010cites this paper
• The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer

  2010cites this paper
• COX-2 expression in canine normal and neoplastic mammary gland.

  2009cites this paper
• Purple sweet potato color attenuates oxidative stress and inflammatory response induced by d-galactose in mouse liver.

  2009cites this paper
• Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.

  2009cites this paper
• Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study

  2009cites this paper
• Overexpression of connexin26 in the basal keratinocytes reduces sensitivity to tumor promoter TPA

  2009cites this paper
• What is the future for NSAIDS in preventing breast cancer in older women

  2008cites this paper
• Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.

  2008cites this paper
• Combination Chemoprevention of HER2/neu-Induced Breast Cancer Using a Cyclooxygenase-2 Inhibitor and a Retinoid X Receptor–Selective Retinoid

  2008cites this paper
• Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer

  2007cites this paper
• Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function

  2007cites this paper
• Tumor promotion as a target of cancer prevention.

  2007cites this paper
• The cyclooxygenase‐2‐mediated prostaglandin signaling is causally related to epithelial carcinogenesis

  2007cites this paper
• Combination chemoprevention of HER2/neu-induced breast cancer using a COX-2 inhibitor and an RXR-selective retinoid

  2007cites this paper
• Molecular pathology of breast apocrine carcinomas: A protein expression signature specific for benign apocrine metaplasia

  2006influential citation
• Infection and inflammation : impacts on oncogenesis

  2006cites this paper
• Apocrine Cysts of the Breast

  2006cites this paper
• Differential Protein Expression in the Epidermis of Wild-Type and COX-2 Transgenic Mice

  2006cites this paper
• The inflammatory tumor microenvironment and its impact on cancer development.

  2006cites this paper
• What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?

  2006cites this paper
• Current directions for COX-2 inhibition in breast cancer.

  2005cites this paper
• Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression.

  2005cites this paper
• Myoepithelial Cells in the Control of Mammary Development and Tumorigenesis: Data From Genetically Modified Mice

  2005influential citation